- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Voyager Therapeutics Inc (VYGR)
Voyager Therapeutics Inc stock price live, this page displays NASDAQ VYGR stock exchange data. View the VYGR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Voyager Therapeutics Inc real time stock price chart below.
What Is the Voyager Therapeutics Inc Stock Price Today?
The Voyager Therapeutics Inc stock price today is 3.405.
What Is the Stock Symbol for Voyager Therapeutics Inc?
The stock ticker symbol for Voyager Therapeutics Inc is VYGR.
Is VYGR the Same as $VYGR?
$VYGR is a common way to refer to the Voyager Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Voyager Therapeutics Inc Trade On?
Voyager Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Voyager Therapeutics Inc a Good Stock to Buy?
Determining whether Voyager Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Voyager Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VYGR quote. (ISIN: US92915B1061)
What Is the Voyager Therapeutics Inc Stock Price Today?
The Voyager Therapeutics Inc stock price today is 3.405.
What Is the Stock Symbol for Voyager Therapeutics Inc?
The stock ticker symbol for Voyager Therapeutics Inc is VYGR.
Is VYGR the Same as $VYGR?
$VYGR is a common way to refer to the Voyager Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Voyager Therapeutics Inc Trade On?
Voyager Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Voyager Therapeutics Inc a Good Stock to Buy?
Determining whether Voyager Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Voyager Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VYGR quote. (ISIN: US92915B1061)
3.405
+0.085(+2.56%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.300
3.415
52 wk Range
2.935
5.550
VYGR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.3003.415
52 wk Range
2.9355.550
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VYGR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
14.889
Upside
+337.27%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
8 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
11 Buy
0 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.889
(+337.27% Upside)
Voyager Therapeutics Inc Earnings Call Summary for Q4/2024
- Voyager Therapeutics reported Q4 2024 EPS of -0.37, in line with expectations, but stock fell 8.82% to $3.62 in after-hours trading
- Company maintains strong $332M cash position and $8.2B in potential milestone payments, with cash runway extending to mid-2027
- VY1706 tau silencing gene therapy advanced to IND-enabling studies; IND submission expected in 2026 with initial tau PET data in H2 2026
- CEO emphasized potential for gene therapy value creation despite setbacks; CMO highlighted need for multiple Alzheimer's treatment options
- Market reaction reflects investor concerns over financial performance and growth prospects, despite strong cash position and pipeline progress
Last Updated: 03/11/2025, 05:40 PM
Read Full TranscriptEarnings
Latest Release
Aug 06, 2026
EPS / Forecast
-0.40 / -0.50
Revenue / Forecast
3.17M / 4.74M
Compare VYGR to Peers and Sector
Metrics to compare | VYGR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVYGRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −8.3x | −0.3x | |
PEG Ratio | −0.73 | 0.01 | 0.00 | |
Price / Book | 1.4x | 6.3x | 2.6x | |
Price / LTM Sales | 6.1x | 20.9x | 3.1x | |
Upside (Analyst Target) | 261.4% | 55.5% | 47.6% | |
Fair Value Upside | Unlock | −7.2% | 5.6% | Unlock |
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease. The company also provides research program for the treatment of Huntington’s disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Voyager Therapeutics Inc (VYGR) Stock Price Today?
The Voyager Therapeutics Inc stock price today is 3.405 USD.
What Stock Exchange Does Voyager Therapeutics Inc Trade On?
Voyager Therapeutics Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Voyager Therapeutics Inc?
The stock symbol for Voyager Therapeutics Inc is "VYGR."
What Is the Voyager Therapeutics Inc Market Cap?
As of today, Voyager Therapeutics Inc market cap is 209.190M USD.
What Is Voyager Therapeutics Inc's Earnings Per Share (TTM)?
The Voyager Therapeutics Inc EPS (TTM) is -1.812.
When Is the Next Voyager Therapeutics Inc Earnings Date?
Voyager Therapeutics Inc will release its next earnings report on Nov 10, 2026.
From a Technical Analysis Perspective, Is VYGR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Voyager Therapeutics Inc Stock Split?
Voyager Therapeutics Inc has split 0 times.
How Many Employees Does Voyager Therapeutics Inc Have?
Voyager Therapeutics Inc has 141 employees.
What is the current trading status of Voyager Therapeutics Inc (VYGR)?
As of Aug 21, 2026, Voyager Therapeutics Inc (VYGR) is trading at a price of 3.405 USD, with a previous close of 3.320 USD. The stock has fluctuated within a day range of 3.300 USD to 3.415 USD, while its 52-week range spans from 2.935 USD to 5.550 USD.
What Is Voyager Therapeutics Inc (VYGR) Price Target According to Analysts?
The average 12-month price target for Voyager Therapeutics Inc is 14.889 USD, with a high estimate of 25 USD and a low estimate of 8 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +337.27% Upside potential.
What Is the VYGR Premarket Price?
VYGR's last pre-market stock price is 3.390 USD. The pre-market share volume is 1,560.000, and the stock has decreased by 0.070, or 2.110%.
What Is the VYGR After Hours Price?
VYGR's last after hours stock price is 3.330 USD, the stock has decreased by 0.010, or 0.300%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.